FTC Sues Hims & Hers Over Privacy Breaches and Misleading Practices

The Federal Trade Commission (FTC) has filed a lawsuit against telehealth company Hims & Hers, accusing the firm of misleading consumers about its privacy practices, billing methods, and subscription terms. The case, which also involves officials from Utah and Los Angeles County, highlights significant concerns over how consumer health data is handled in the digital age.

The FTC alleges that Hims & Hers shared sensitive health information with third-party advertising platforms, including Meta and Snap, despite assuring users that their privacy would be protected. This breach of trust has sparked outrage among consumers who rely on telehealth services for conditions ranging from hair loss to mental health issues. The lawsuit also accuses the company of failing to clearly disclose its billing practices and making it difficult for customers to cancel subscriptions.

Hims & Hers operates a multi-specialty telehealth platform that connects patients with licensed healthcare providers for personalized, direct-to-consumer medical treatment. Over the past few years, the company has seen rapid growth, particularly in its telehealth service for GLP-1 prescriptions, which are used for weight management and diabetes treatment. However, this lawsuit could have far-reaching implications for how such companies manage and protect consumer data.

The FTC's Case Against Hims & Hers

In the complaint filed in federal court, the FTC and its state and local partners detail several alleged infractions by Hims & Hers. One of the primary concerns is the company’s handling of sensitive health information. According to the FTC, Hims & Hers shared lists of certain customers with third-party advertising platforms, including Meta and Snap. This sharing was allegedly done through third-party tracking technologies that automatically transmitted specific "Events"-actions taken by visitors on Hims' website-to these companies.

The complaint also highlights issues with billing practices. The FTC alleges that Hims & Hers charges consumers for prescriptions almost immediately after they submit an intake form, despite telling them they would have the opportunity to consult with a medical provider to find a treatment plan that is "right for them." This immediate billing without clear disclosure can lead to unexpected charges and financial stress for patients.

The FTC accuses Hims & Hers of making it difficult for consumers to cancel subscriptions. The complaint states that the company misled users about their ability to manage and terminate these recurring payments easily. These practices not only violate consumer trust but also raise serious ethical questions about the transparency and fairness of telehealth services.

The impact of this lawsuit on Hims & Hers is already evident in its stock performance. As of Wednesday, the company's stock dropped by 14%, reflecting investor concerns over the legal and reputational risks associated with these allegations.

What Comes Next

The FTC’s lawsuit against Hims & Hers serves as a wake-up call for the telehealth industry. It underscores the critical need for companies to prioritize transparency, data protection, and consumer rights in their operations. As more patients turn to telehealth services for convenient and accessible healthcare, ensuring that these platforms are trustworthy and reliable becomes increasingly important.

For consumers, this case highlights the importance of carefully reviewing privacy policies and terms of service before engaging with telehealth providers. It also emphasizes the need for stronger regulatory oversight to protect patient data and prevent misleading practices. The outcome of this lawsuit could set a precedent for how telehealth companies operate and how they are held accountable for their actions.

As the legal proceedings unfold, it will be crucial to monitor the responses from Hims & Hers and other industry players. The decisions made in this case could have lasting implications for the future of telehealth and the trust that patients place in these services.